{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:40:39Z","timestamp":1788698439184,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jhsa.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T08:21:44Z","timestamp":1584778904000},"page":"779.e1-779.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Management of Perioperative Immunosuppressant Medications for Rheumatoid Arthritis During Elective Hand Surgery"],"prefix":"10.1016","volume":"45","author":[{"given":"Kevin M.","family":"Klifto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Lifchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jhsa.2020.02.005_bib1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.5435\/JAAOS-D-15-00014","article-title":"Perioperative treatment of patients with rheumatoid arthritis","volume":"23","author":"Saleh","year":"2015","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.jhsa.2020.02.005_bib2","doi-asserted-by":"crossref","first-page":"648073","DOI":"10.1155\/2015\/648073","article-title":"Current concepts in the management of rheumatoid hand","volume":"2015","author":"Longo","year":"2015","journal-title":"Int J Rheumatol"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3904\/kjim.2015.137","article-title":"Current concepts in the management of rheumatoid arthritis","volume":"31","author":"Tanaka","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.jhsa.2020.02.005_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/jhsu.2002.32958","article-title":"Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery","volume":"27","author":"Jain","year":"2002","journal-title":"J\u00a0Hand Surg Am"},{"issue":"5","key":"10.1016\/j.jhsa.2020.02.005_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/14397595.2015.1014302","article-title":"Postoperative complications in patients with rheumatoid arthritis using a biological agent\u2014a systematic review and meta-analysis","volume":"25","author":"Ito","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.jhsa.2020.02.005_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1756-185X.2010.01579.x","article-title":"Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab","volume":"14","author":"Hayata","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-014-3121-0","article-title":"Perioperative use of anti-rheumatic agents does not increase early postoperative infection risks: a Veteran Affairs' administrative database study","volume":"35","author":"Abou Zahr","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jhsa.2020.02.005_bib8","doi-asserted-by":"crossref","first-page":"251962","DOI":"10.5402\/2012\/251962","article-title":"Wound healing with medications for rheumatoid arthritis in hand surgery","volume":"2012","author":"Barnard","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"6","key":"10.1016\/j.jhsa.2020.02.005_bib9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10067-016-3274-1","article-title":"Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs","volume":"35","author":"Tada","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jhsa.2020.02.005_bib10","doi-asserted-by":"crossref","first-page":"w14563","DOI":"10.4414\/smw.2017.14563","article-title":"The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis","volume":"147","author":"Fleury","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.21841","article-title":"Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis","volume":"55","author":"Giles","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jhsa.2020.02.005_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/21548331.2017.1359060","article-title":"Update in perioperative medicine: practice changing evidence published in 2016","volume":"45","author":"Regan","year":"2017","journal-title":"Hosp Pract (1995)"},{"issue":"3","key":"10.1016\/j.jhsa.2020.02.005_bib13","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen-Witrand","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-017-3965-2","article-title":"Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment","volume":"37","author":"Chen","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/229255031602400201","article-title":"Adverse outcomes following hand surgery in patients with rheumatoid arthritis","volume":"24","author":"Menchaca-Tapia","year":"2016","journal-title":"Plast Surg (Oakv)"},{"key":"10.1016\/j.jhsa.2020.02.005_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12891-016-1038-3","article-title":"The challenging interplay between rheumatoid arthritis, ageing and comorbidities","volume":"17","author":"van Onna","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"10.1016\/j.jhsa.2020.02.005_bib17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jhsa.2020.02.005_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02032339","article-title":"Postoperative wound infection in rheumatoid arthritis surgery","volume":"3","author":"Hamalainen","year":"1984","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.1780340204","article-title":"Local infectious\u00a0complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate","volume":"34","author":"Perhala","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jhsa.2020.02.005_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00296-009-0948-x","article-title":"Late infection of total knee arthroplasty inflamed by anti-TNFalpha, infliximab therapy in rheumatoid arthritis","volume":"30","author":"Yurube","year":"2010","journal-title":"Rheumatol Int"},{"issue":"22","key":"10.1016\/j.jhsa.2020.02.005_bib21","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/archinte.166.22.2525","article-title":"Potentially unintended discontinuation of long-term medication use after elective surgical procedures","volume":"166","author":"Bell","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jhsa.2020.02.005_bib22","first-page":"150","article-title":"Risk factors for late deep infection after total hip arthroplasty in patients with rheumatoid arthritis","volume":"42","author":"Hayashi","year":"2017","journal-title":"Acta Reumatol Port"},{"issue":"8","key":"10.1016\/j.jhsa.2020.02.005_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/acr.23274","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502320300824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502320300824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:58:04Z","timestamp":1759791484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502320300824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0363502320300824"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2020.02.005","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Management of Perioperative Immunosuppressant Medications for Rheumatoid Arthritis During Elective Hand Surgery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Society for Surgery of the Hand. All rights reserved.","name":"copyright","label":"Copyright"}]}}